Connection
Fen Xia to Tumor Burden
This is a "connection" page, showing publications Fen Xia has written about Tumor Burden.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.130 |
|
|
|
-
Jiang J, Lu Y, Li Z, Li L, Niu D, Xu W, Liu J, Fu L, Zhou Z, Gu Y, Xia F. Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery. Invest New Drugs. 2017 06; 35(3):251-259.
Score: 0.130